Question 1

What are the active compounds in Wollemia nobilis?

Accepted Answer

Wollemia nobilis contains biflavones, terpenes, and flavonoids—compounds commonly found in conifers with potential antioxidant and anti-inflammatory properties. However, research on this species is extremely limited due to its recent discovery in 1994 and critically endangered status. No clinical studies have established specific mechanisms of action for medicinal purposes. Evidence Level: C (preliminary phytochemical research only).

Question 2

Does Wollem Pine interact with any medications?

Accepted Answer

No drug interaction studies exist for Wollemia nobilis. Given the absence of clinical research and established medicinal use, potential interactions with medications, supplements, or health conditions remain unknown. The species' critically endangered conservation status prohibits collection, meaning no standardized preparations exist for therapeutic use. Evidence Level: C (insufficient data).

Question 3

What is the recommended dosage for Wollemia nobilis?

Accepted Answer

No established therapeutic dosage exists for Wollemia nobilis. The species was discovered only in 1994 and has extremely limited documented medicinal history. Its critically endangered status under Australian law prohibits wild collection, and no commercial preparations are available. Any traditional use information is anecdotal and unsupported by clinical research. Evidence Level: C (no established dosage).

Question 4

Is Wollemia nobilis safe to use during pregnancy?

Accepted Answer

Wollemia nobilis is considered unsafe during pregnancy and breastfeeding. No safety data exists for this species, and potential risks to fetal development cannot be assessed. Additionally, the plant's critically endangered conservation status means it should not be collected or used under any circumstances. Pregnant individuals should avoid all exposure to this species. Evidence Level: C (insufficient safety data).

Question 5

What are the medicinal uses of Wollem Pine?

Accepted Answer

Wollemia nobilis has extremely limited documented medicinal use. Discovered in 1994 in a remote Australian canyon, this 'living fossil' holds primarily conservation significance rather than therapeutic applications. Preliminary phytochemical analysis has identified biflavones and terpenes, but no clinical trials support any specific health benefits. Traditional use information is minimal due to the species' isolated habitat and recent scientific discovery. Evidence Level: C (limited traditional use).

Question 6

Why is Wollemia nobilis protected from collection?

Accepted Answer

Wollemia nobilis is classified as critically endangered, with fewer than 100 mature trees known in the wild. Australian law strictly prohibits collection, and international trade is regulated under CITES. The species faces threats from disease, fire, and habitat disturbance. Conservation efforts focus on protecting wild populations, making any medicinal collection both illegal and ecologically irresponsible. Evidence Level: A (confirmed conservation status).

Wollemia nobilis

Sources & Citations

Summary

Background

Active compounds

Clinical evidence

Evidence summary

PubMed sources

Government sources